monoclonal antibodies
EXCLUSIVE. Redefining Treatment: Sandoz Experts Pioneering Biosimilars for Life-Changing Therapies
At Sandoz, scientists are driving the next generation of biosimilars for monoclonal antibodies and recombinant proteins—innovations that bring advanced, reliable treatments for cancer, autoimmune diseases, and growth disorders within reach of more patients worldwide.